Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

Summary

To test the hypothesis that Teriparatide injections given 20 micrograms/daily subcutaneously, for one month, are able to produce reliable changes in the bone marker in a severe osteoporotic population

Timeline

Start

2003-04

Primary completion

—

Completion

2004-04

Drugs

Indications